Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease

Miho Nakamura, Hidetoshi Nakamura, Naoto Minematsu, Shotaro Chubachi, Masaki Miyazaki, Shuichi Yoshida, Keishi Tsuduki, Toru Shirahata, Shuko Mashimo, Saeko Takahashi, Takahiro Nakajima, Hiroki Tateno, Seitaro Fujishima, Tomoko Betsuyaku

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease (COPD) develops only in smoking-sensitive smokers and manifests heterogeneous phenotypes, including emphysema and non-emphysema types. We aimed to identify biomarkers related to the smoking-sensitivity and phenotypes of COPD. Among 240 smokers suggestive of COPD, we studied on four groups defined by % forced expiratory volume in one second (FEV1) and computed tomography-based pulmonary emphysema. Plasma concentrations of 33 inflammatory markers were measured in four groups as well as Non-smokers using multiplex protein arrays. IL-5, IL-7 and IL-13 were identified to be associated with smoking sensitivity and IL-6 and IL-10 were candidate biomarkers for airway-lesion dominant COPD.

Original languageEnglish
Pages (from-to)368-377
Number of pages10
JournalBiomarkers
Volume19
Issue number5
DOIs
Publication statusPublished - 2014

Fingerprint

Pulmonary diseases
Chronic Obstructive Pulmonary Disease
Smoking
Cytokines
Phenotype
Plasmas
Biomarkers
Interleukin-7
Protein Array Analysis
Pulmonary Emphysema
Interleukin-13
Interleukin-5
Emphysema
Forced Expiratory Volume
Interleukin-10
Tomography
Interleukin-6
Proteins

Keywords

  • Airflow limitation
  • Chronic obstructive pulmonary disease
  • Emphysema
  • Inflammatory cytokine
  • Plasma biomarker

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Health, Toxicology and Mutagenesis
  • Medicine(all)

Cite this

Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease. / Nakamura, Miho; Nakamura, Hidetoshi; Minematsu, Naoto; Chubachi, Shotaro; Miyazaki, Masaki; Yoshida, Shuichi; Tsuduki, Keishi; Shirahata, Toru; Mashimo, Shuko; Takahashi, Saeko; Nakajima, Takahiro; Tateno, Hiroki; Fujishima, Seitaro; Betsuyaku, Tomoko.

In: Biomarkers, Vol. 19, No. 5, 2014, p. 368-377.

Research output: Contribution to journalArticle

Nakamura, M, Nakamura, H, Minematsu, N, Chubachi, S, Miyazaki, M, Yoshida, S, Tsuduki, K, Shirahata, T, Mashimo, S, Takahashi, S, Nakajima, T, Tateno, H, Fujishima, S & Betsuyaku, T 2014, 'Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease', Biomarkers, vol. 19, no. 5, pp. 368-377. https://doi.org/10.3109/1354750X.2014.915342
Nakamura, Miho ; Nakamura, Hidetoshi ; Minematsu, Naoto ; Chubachi, Shotaro ; Miyazaki, Masaki ; Yoshida, Shuichi ; Tsuduki, Keishi ; Shirahata, Toru ; Mashimo, Shuko ; Takahashi, Saeko ; Nakajima, Takahiro ; Tateno, Hiroki ; Fujishima, Seitaro ; Betsuyaku, Tomoko. / Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease. In: Biomarkers. 2014 ; Vol. 19, No. 5. pp. 368-377.
@article{7b2662945bd843c7b2c141463eff2a86,
title = "Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease",
abstract = "Chronic obstructive pulmonary disease (COPD) develops only in smoking-sensitive smokers and manifests heterogeneous phenotypes, including emphysema and non-emphysema types. We aimed to identify biomarkers related to the smoking-sensitivity and phenotypes of COPD. Among 240 smokers suggestive of COPD, we studied on four groups defined by {\%} forced expiratory volume in one second (FEV1) and computed tomography-based pulmonary emphysema. Plasma concentrations of 33 inflammatory markers were measured in four groups as well as Non-smokers using multiplex protein arrays. IL-5, IL-7 and IL-13 were identified to be associated with smoking sensitivity and IL-6 and IL-10 were candidate biomarkers for airway-lesion dominant COPD.",
keywords = "Airflow limitation, Chronic obstructive pulmonary disease, Emphysema, Inflammatory cytokine, Plasma biomarker",
author = "Miho Nakamura and Hidetoshi Nakamura and Naoto Minematsu and Shotaro Chubachi and Masaki Miyazaki and Shuichi Yoshida and Keishi Tsuduki and Toru Shirahata and Shuko Mashimo and Saeko Takahashi and Takahiro Nakajima and Hiroki Tateno and Seitaro Fujishima and Tomoko Betsuyaku",
year = "2014",
doi = "10.3109/1354750X.2014.915342",
language = "English",
volume = "19",
pages = "368--377",
journal = "Biomarkers",
issn = "1354-750X",
publisher = "Informa Healthcare",
number = "5",

}

TY - JOUR

T1 - Plasma cytokine profiles related to smoking-sensitivity and phenotypes of chronic obstructive pulmonary disease

AU - Nakamura, Miho

AU - Nakamura, Hidetoshi

AU - Minematsu, Naoto

AU - Chubachi, Shotaro

AU - Miyazaki, Masaki

AU - Yoshida, Shuichi

AU - Tsuduki, Keishi

AU - Shirahata, Toru

AU - Mashimo, Shuko

AU - Takahashi, Saeko

AU - Nakajima, Takahiro

AU - Tateno, Hiroki

AU - Fujishima, Seitaro

AU - Betsuyaku, Tomoko

PY - 2014

Y1 - 2014

N2 - Chronic obstructive pulmonary disease (COPD) develops only in smoking-sensitive smokers and manifests heterogeneous phenotypes, including emphysema and non-emphysema types. We aimed to identify biomarkers related to the smoking-sensitivity and phenotypes of COPD. Among 240 smokers suggestive of COPD, we studied on four groups defined by % forced expiratory volume in one second (FEV1) and computed tomography-based pulmonary emphysema. Plasma concentrations of 33 inflammatory markers were measured in four groups as well as Non-smokers using multiplex protein arrays. IL-5, IL-7 and IL-13 were identified to be associated with smoking sensitivity and IL-6 and IL-10 were candidate biomarkers for airway-lesion dominant COPD.

AB - Chronic obstructive pulmonary disease (COPD) develops only in smoking-sensitive smokers and manifests heterogeneous phenotypes, including emphysema and non-emphysema types. We aimed to identify biomarkers related to the smoking-sensitivity and phenotypes of COPD. Among 240 smokers suggestive of COPD, we studied on four groups defined by % forced expiratory volume in one second (FEV1) and computed tomography-based pulmonary emphysema. Plasma concentrations of 33 inflammatory markers were measured in four groups as well as Non-smokers using multiplex protein arrays. IL-5, IL-7 and IL-13 were identified to be associated with smoking sensitivity and IL-6 and IL-10 were candidate biomarkers for airway-lesion dominant COPD.

KW - Airflow limitation

KW - Chronic obstructive pulmonary disease

KW - Emphysema

KW - Inflammatory cytokine

KW - Plasma biomarker

UR - http://www.scopus.com/inward/record.url?scp=84904701248&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904701248&partnerID=8YFLogxK

U2 - 10.3109/1354750X.2014.915342

DO - 10.3109/1354750X.2014.915342

M3 - Article

VL - 19

SP - 368

EP - 377

JO - Biomarkers

JF - Biomarkers

SN - 1354-750X

IS - 5

ER -